Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
4.400
0.00 (0.00%)
Oct 30, 2025, 9:27 AM EDT - Market open
AVR Employees
Anteris Technologies Global had 136 employees as of December 31, 2024.
Employees
136
Change
n/a
Growth
n/a
Revenue / Employee
$18,228
Profits / Employee
-$617,147
Market Cap
178.88M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 136 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AVR News
- 2 days ago - Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”) - GlobeNewsWire
- 3 days ago - Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025 - GlobeNewsWire
- 5 weeks ago - Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders - GlobeNewsWire
- 7 weeks ago - Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders - GlobeNewsWire
- 2 months ago - Anteris Announces Results for the Second Quarter of 2025 - GlobeNewsWire
- 5 months ago - Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - GlobeNewsWire
- 7 months ago - Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewsWire
- 7 months ago - Anteris Reports One-Year Patient Outcomes for DurAVR® THV - GlobeNewsWire